WANDA MOONEY: Open Payments
NPI 1316557705 · PARAGOULD, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$377 in 14 payments from 9 companies in 2025. Trend: 2023 $179 · 2024 $396 · 2025 $377
Food & beverage: $377
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $168 |
| Biogen, Inc. | 4 | $79 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $30 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| Inspire Medical Systems, Inc. | 1 | $19 |
| Organon LLC | 1 | $18 |
| Novo Nordisk Inc | 1 | $16 |
| MILLICENT US INC | 1 | $16 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $7 |
Products named: QULIPTA, ZURZUVAE, UBRELVY, JOURNAVX, GEMTESA, INSPIRE, NEXPLANON, FEMRING.
Industry payments across AR — which companies pay providers there.
